August 30, 2022
August 26, 2022
1,957 prescribers tell FDA: Preserve access to compounded hormones
Earlier this week, APC submitted a letter signed by nearly 2,000 prescribers of compounded hormones to FDA Commissioner Robert Califf, urging FDA to assure continued patient access to compounded hormone therapy.
August 26, 2022
FDA’s Gail Bormel to appear at CCH
FDA’s director of the Office of Compounding Quality and Compliance, Gail Bormel, has accepted APC’s invitation to attend Compounders on Capitol Hill.
August 26, 2022
Ready/not ready for GFI #256? Tell us!
Help us help YOU get ready for GFI #256 by taking a quick survey.
August 24, 2022
Nearly 2,000 prescribers urge FDA: Preserve access to compounded hormones
A letter signed by 1,957 prescribers of compounded hormones was submitted this week to FDA Commissioner Robert Califf urging that he preserve continued patient access to compounded hormone therapy.
August 19, 2022
Free webinar: How GFI 256 will change your compounding practice
Maybe you’ve heard about FDA’s GFI 256, regarding animal compounding, and wondered if it might affect mew.
August 19, 2022
CCH is less than a month away
Here are five compelling reasons you should join us in DC next month...
August 19, 2022
Dear Congress: Save compounded hormones!
3,222 folks have sent 9,370 cBHT messages to 269 members of Congress.
